The Mitogen Activated Protein Kinase 3 pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Mitogen Activated Protein Kinase 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Immunology, Cardiovascular, and Central Nervous System which include the indications Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Hypertension, Alzheimer’s Disease, and Parkinson’s Disease. It also reviews key players involved in Mitogen Activated Protein Kinase 3 targeted therapeutics development with respective active and dormant or discontinued products.
The Mitogen Activated Protein Kinase 3 pipeline targets constitutes close to 16 molecules. Out of which, approximately 14 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, and Preclinical stages are 1, 5, 5, and 2 respectively. Similarly, the universities portfolio in Preclinical, and Discovery comprises 1, and 1 molecule.
Mitogen Activated Protein Kinase 3 overview
Mitogen-activated protein kinase 3 is an enzyme encoded by the MAPK3 gene. It acts in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. It is activated by upstream kinases resulting in its translocation to the nucleus where it phosphorylates nuclear targets.
For a complete picture of Mitogen Activated Protein Kinase 3’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.